We’ve adopted a new multidisciplinary approach for providing preemptive hemodynamic support to enable VT ablation in patients otherwise too vulnerable to procedural risks.
A large case series shows that catheter ablation of refractory ventricular arrhythmia in patients with cardiogenic shock can allow for liberation from mechanical support in most cases.
The studies explore a novel catheter that delivers both pulsed-field and radiofrequency energy, a new method for mapping and ablating scar-related ventricular tachycardia, and high-power/short-duration ablation for atrial fibrillation.
In ablation of scar-related ventricular tachycardia, mapping the heart during activation from multiple directions promises to improve clinical outcomes, suggests the international Physio-VT trial.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
We’ve been pioneering use of the Impella 5.0 temporary LVAD to support patients with cardiogenic shock who need salvage ablation for ventricular tachycardia. This case study shares lessons learned to date.